Home / Cellectar Biosciences, Inc. (CLRB)

Cellectar Biosciences, Inc. (CLRB) Technical Analysis

Updated: 2026-03-17 00:35 UTC · Last close: 3.27 (+2.19%)
Cellectar Biosciences, Inc. (CLRB) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
Support
3.23
Resistance
7.33
Cellectar Biosciences, Inc. (CLRB) closed at 3.27 (+2.19%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is running at -0.61%, with price is trading in the lower part of its roughly 52-week range (2.56–13.80), while ATR14 volatility is elevated at roughly 9.85% of price. RSI(14) is 53.7, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. From a pattern perspective, the main active signal is Double bottom. The nearest decision zone is framed by support at 3.23 and resistance at 7.33. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Net income: -21.79M · EPS (basic): -8.35. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
Cellectar Biosciences, Inc.
CIK (SEC ID)
0001279704
Shares Out.
4.24M
Net Income
-21.79M
EPS (Basic)
-8.35
Explore more
Uber Technologies (UBER) technical analysisAirbnb (ABNB) technical analysisPalantir Technologies (PLTR) technical analysisCoinbase Global (COIN) technical analysisSnap (SNAP) technical analysisSoFi Technologies (SOFI) technical analysisShopify (SHOP) technical analysis
WOI OPEN FULL INTERACTIVE ANALYSIS
Note: This is an algorithmic technical snapshot (not financial advice).
CLRB Chart